CannabisNewsBreaks

WednesdaySep 20, 2017 11:16 am

CannabisNewsBreaks – Terra Tech Corp. (TRTC) Signs Second Craft Cultivator to Grow Proprietary Cannabis Brand

Terra Tech Corp. (OTCQX: TRTC), a vertically integrated cannabis-focused agriculture company, recently announced a new farm partnership with a second Craft Cultivator to grow the company’s proprietary high grade “IVXX” cannabis flowers and oils. The farm, Cultivar Inc., located in Salinas, California, is approved for up to six acres (approximately 244,000 square feet) of cannabis cultivation in high tech, climate-controlled greenhouses. “We selected Cultivar to be our newest Cannabis Craftsman as it uses an all-natural cultivation methodology that upholds the high standards associated with our proprietary IVXX brand, including sustainable farming practices and the production of pesticide-free cannabis products,” Derek…

Continue Reading

TuesdaySep 19, 2017 9:22 am

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Retains Consulting Services of Ben Paterson

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced that it has retained the consulting services of Ben Paterson, P.E., to assist in defining the pathway for scale-up, purification and manufacturing strategies related to the company’s cannabinoid biosynthesis program. Paterson brings nearly four decades of experience in developing pharmaceutical manufacturing and purification processes to the InMed team, having previously served as a senior engineering advisor with Pharmaceutical giant Eli Lilly and Company for nearly four decades. “Mr. Paterson brings significant experience in all facets of biosynthesis manufacturing and facility design,” Eric A. Adams, president and…

Continue Reading

MondaySep 18, 2017 10:22 am

CannabisNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Nets Total Proceeds of $11.9 Million from Exercise of Warrants

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced that it has received total proceeds of nearly $11.9 million from the exercise of an aggregate of 19,185,965 warrants since the closing of its acquisition of ABcann Medicinals Inc. on April 28, 2017. With these funds, ABcann’s current cash position stands at approximately $45 million, giving the company the means to execute previously outlined plans to expand its production capabilities. “ABcann thanks our shareholders for their continued support and confidence as we work toward expanding our facilities and increasing production,” Aaron Keay, director and CEO of ABcann, stated in the…

Continue Reading

FridaySep 15, 2017 2:01 pm

CannabisNewsBreaks – Organigram (TSX.V: OGI) (OTCQB: OGRMF) Signs MOU with Canadian Provincial Authority for Distribution of Cannabis to Adult Recreational Market

Organigram Holdings Inc. (TSX.V: OGI) (OTCQB: OGRMF), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, today announced it has entered into a memorandum of understanding (MOU) with the New Brunswick provincial authority for the distribution of marijuana to the adult-use recreational market. Through the MOU, New Brunswick secures a supply of at least five million grams of recreational marijuana per year from Organigram. In a news release, Organigram CEO Greg Engel said, “We applaud the New Brunswick government’s efforts to foster an innovative, forward-thinking economic climate that supports cannabis as a driver of growth for New…

Continue Reading

FridaySep 15, 2017 1:58 pm

CannabisNewsBreaks – University of British Columbia to Conduct Clinical Study of Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Game-Changing Oral CBD Product

While cannabidiol and other marijuana-derived substances are traditionally smoked, this can cause damage to the lungs, and edible cannabis products have their drawbacks, too—typically being filled with sugars or other sweeteners to mask the unpleasant flavor associated with cannabis compounds. With its pioneering TurboCBD™ product, however, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral CBD intake, having engineered the product to enhance absorption through the intestinal tract without active compounds being destroyed by stomach acid or broken down by the liver, and this revolutionary product also masks the unpleasant flavor of cannabis compounds. An article further discussing this…

Continue Reading

FridaySep 15, 2017 1:36 pm

CannabisNewsBreaks – Recent Competitor Recalls Illustrate Importance of ABcann Global’s (TSX.V: ABCN) (OTCQB: ABCCF) Innovative, Pesticide-Free Cannabis Growth Practices

Recently, the Canadian government announced that Broken Coast Cannabis Ltd. was recalling several products sold in 2016 due to the discovery of two banned pesticides in random samples, and several other Canadian cannabis growers have also had product recalls this year after banned pesticides were discovered in their products during mandatory testing. Instances like these serve to further illustrate the importance of the controlled, pesticide-free medical marijuana growth practices of ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), which continues to meet product demand through its Napanee, Ontario, production facility and is also moving forward with expansion plans. An article further…

Continue Reading

WednesdaySep 13, 2017 2:15 pm

CannabisNewsBreaks – The Green Organic Dutchman Holdings Secures $20M Pre-IPO Financing Agreement

The Green Organic Dutchman Holdings Ltd. (“TGOD”) earlier this week announced a $20 million private placement with a syndicate led by PI Financial Corp., priced at C$1.65 per unit. Shares will have a six-month hold period from the day of the company’s initial public offering (IPO), which is anticipated in January of 2018. The medicinal cannabis producer said it plans to use the net proceeds to advance its facilities in Ontario and Quebec, as well as for working capital purposes. View the full press release at http://cnw.fm/WWP6b About The Green Organic Dutchman Ltd. The Green Organic Dutchman Ltd. grows high…

Continue Reading

WednesdaySep 13, 2017 2:14 pm

CannabisNewsBreaks – Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) Harvests First California Cannabis Crop

Future Farm Technologies Inc. (CSE: FFT) (OTCQB: FFRMF) recently announced the harvest of its first cannabis crop from its previously announced Riverside County, California, cultivation facility. The company is currently drying, curing, trimming and packaging the flower in preparation for sale and distribution to medical patients in California later this month. Future Farm estimates the harvest of approximately 90 pounds with a market value of $144,000-$180,000. A video of the cultivation facility, filmed in July, is also online and available for viewing. To view the full press release, visit http://cnw.fm/66Ajl About Future Farm Technologies Inc. Future Farm’s business model includes…

Continue Reading

TuesdaySep 12, 2017 9:54 am

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Files Provisional Patent Covering Proprietary Biosynthesis Program

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its filing of a provisional patent application pertaining to the company’s biosynthesis program for the manufacture of cannabinoids that are identical to those found in nature. Per the news release, this patent application, once converted into an international Patent Cooperation Treaty (PCT) application and pursued in key jurisdictions around the world, will offer significant commercial protections for InMed’s promising E. coli-based expression system, which enables the manufacture of any of the 90+ cannabinoid compounds found in the cannabis plant. “This novel approach to the biosynthesis of…

Continue Reading

MondaySep 11, 2017 1:11 pm

CannabisNewsBreaks – Tetra Bio-Pharma (TSX.V: TBP) (OTCQB: TBPMF) Accelerates its Cannabis-based Clinical Research Program in the Veterinary Market

Tetra Bio-Pharma (TSX.V: TBP) (OTCQB: TBPMF), a biopharmaceutical leader in cannabinoid-based drug discovery and development, is adding international expert Dr. Louis-Philippe de Lorimier, a board certified veterinary oncologist, to its clinical advisory board for the veterinary market. In a news release, Dr. Guy Chamberland, chief scientific officer of Tetra Bio-Pharma, said, "We are leveraging our current R&D work in humans to accelerate the development of the first cannabinoid-based drug for pets in the cancer-associated supportive therapy market, including pain. This market is underserved and patients and their owner are waiting for alternatives that are safer, more tolerable and more efficacious.”…

Continue Reading